期刊文献+

重组人促红细胞生成素促进猪缺血心肌血管生成的实验研究 被引量:2

Effects of recombinant human erythropoietin on angiogenesis in chronic ischemic porcine myocardium
原文传递
导出
摘要 目的 观察重组人促红细胞生成素(rhEPO)对猪缺血心肌的血管生成效应及其作用机制.方法 选用12只6~8个月的巴马小型猪,应用胸腔镜微创技术将血管缩窄环放置于回旋支,利用心电图、冠状动脉造影评估回旋支闭塞或相应心肌缺血的程度,建立猪慢性心肌缺血模型.治疗组6只分别于建模后第1、3、7、14、21天皮下注射6 000 U rhEPO,对照组6只于同样的时间点皮下注射等量的生理盐水.用ELISA法检测治疗前及治疗后第3、7、14、21天血清中血管内皮生长因子(VEGF)蛋白的分泌;28 d后行超声心动图检测左心室功能变化,行冠状动脉造影进行回旋支血流分级;取各组心肌,采用Western blot法检测VEGF、磷酸化蛋白激酶B(p-Akt)、磷酸化细胞外信号调节激酶(p-Erk)的表达,免疫组化染色法检测毛细血管和小动脉生成情况.结果 rhEPO治疗后第3天血清VEGF分泌水平达到高峰,至第28天时回落至接近基础水平;rhEPO治疗后,治疗组心功能较对照组改善明显;Western blot检测结果显示rhEPO治疗后1个月,VEGF、p-Akt和p-Erk蛋白表达水平都有不同水平的升高,其相对表达量分别是对照组的2.5倍、1.1倍和1.5倍(t=37.721、10.907、12.957,P均=0.000).治疗组心肌毛细血管密度和小动脉密度分别为(944±98)%/mm2和(73±13) %/mm2,对照组分别为(569±102) %/mm2和(45±10)%/mm2,差异均有统计学意义(=4.214、2.869,P=0.016、0.023).结论 rhEPO可促进猪缺血心肌血管的生成,其机制可能是通过上调p-Akt、p-Erk的表达实现的. Objective To investigate the effect and mechanism of recombinant human erythropoietin (rhEPO) on angiogenesis in chronic ischemic porcine myocardium. Methods A ameroid constrictor was placed around the proximal circumflex branch of the left coronary artery in 12 Bama miniatures' swine artery by thoracoscopy. Electrocardiogram and coronary angiography were used to confirm the establishment of myocardial ischemia. The animals were divided into rhEPO treatment group (n = 6) and negative control group (n =6). Treatment group received subcutaneous injection of rhEPO at 1,3,7,14,21 days, control group received saline. The expression of vascular endothelial growth factor (VEGF) in serum was assessed by ELISA. Uhrasonography and coronary angiography were assessed 28 days after therapy. Western blot was used to detect the expression of VEGF, phosphorylated protein kinase B (p-Akt) and phosphorylated extracellular signal regulated kinases (p-Erk). The degree of angiogenesis was assessed by immunohistochemical analysis. Results Serum VEGF rose significantly in both control and treatment groups, peaking at 3 days and then returning to the near-baseline level at 28 days, but the two groups showed no significant difference at each time point (P 〉 0. 05 ). Echocardiographic measurements showed that the left ventricular systolic function of animals in treatment group increase significantly after rhEPOtherapy, the expression levels of VEGF, p-Akt and p-Erk had markedly increased, which resulted in a 2. 5- fold increased of VEGF, 1.1-fold increased of p-Akt, 1.5-fold increased of p-Erk ( t = 37. 721, 10. 907, 12. 957, all P = 0. 000). there were significant increase in capillary density and arteriole density in the two groups ((944±98) %/mm2vs. (569+102) %/mm2, (73±3) %/mm2 vs. (45±10) %/mm2, t= 4. 214, 2. 869, P = 0. 016, 0. 023). Conclusions rhEPO can promote angiogenesis and arteriogenesis and improve the left ventricular systolic function in porcine model of chronic myocardial ischemia. The potential menchanism is to up-regulated the expression of p-Akt and p-Erk.
出处 《中华外科杂志》 CAS CSCD 北大核心 2014年第5期366-369,共4页 Chinese Journal of Surgery
基金 浙江省科技计划资助项目(2011C37083)
关键词 红细胞生成素 重组 心肌缺血 血管内皮生长因子类 蛋白激酶类 细胞外信号调节MAP激酶类 Erythropoietin, recombinant Myocardial ischemia Vascular endothelial growth factors Protein kinases Extracellular signal-regulated MAP kinases
  • 相关文献

参考文献12

  • 1Mastrtmmrino V, Musumeci MB, Conti E, et al. Erythropoietin in cardiac disease: effeclive or harmful? [ J ]. J Cardiovasc Med ( Hagerstown ) , 2013, 14 ( 12 ) : 870- 878.
  • 2叶亮,杜心灵,夏家红,江平,王建堂,范慧敏,刘中民.重组人红细胞生成素对心肌梗死治疗作用的实验研究[J].中华医学杂志,2006,86(39):2776-2780. 被引量:6
  • 3Mastromarino V, Volpe M, Musumeci MB, et al. Euthropoietin and Ihe heart:facts and perspectives [ J ]. Clin Sci ( Lond ) , 2011,120(2) :51-63.
  • 4朱成楚,陈仕林,刘玉清,唐礼江,林仙方,包卫光,马德华,朱广球,周文娟,周仪林,杜丛文.rAAV_2VEGF_(165)与rAAV_2ANG-1联合转染促猪缺血心肌血管生成的研究[J].浙江大学学报(医学版),2010,39(6):610-617. 被引量:3
  • 5Fong GH, Rossant J, Gertsenstein M, et al. Role of the Fh-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium [ J ]. Nature, 1995,376( 6535 ) :66-70.
  • 6Hirata A,Minamino T, Asanuma H, et al. Erythropoielin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs [ J ]. J Am Coil Cardiol,2006,48( 1 ) :176-184.
  • 7Westenbrink BD, Lipsie E, van der Meer P, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization[ J ]. Eur Heart J,2007,28(16) :2018-2027.
  • 8Kawaehi K, lso Y, Sato T, et al. Effects of et'ythropoietin on angiogenesis after myocardial infarction in porcine [ J ]. Heart Vessels,2012,27( 1 ) :79-88.
  • 9Wu H,Lee SH,Gao J,et al. Inactivation of erythropoietin leads to defects in cardiac morphogenesis [ J ]. Development, 1999. 126( 16 ) :3597-3605.
  • 10Bullard AJ,Govewalla P, Yellon DM, et al. Eryihropoietin protects the myocardium agaiust reperfusion injury in vitro and in vivo[ J]. Basic Res Cardio1,2005,100(5 ) :397-403.

二级参考文献17

  • 1Rao SV,Stamler JS.Erythropoietin,anemia,and orthostatic hypotension:the evidence mounts.Clin Auton Res,2002,12:141-143.
  • 2Hebert PC,Wells G,Blajchman MA,et al.A multicenter,randomized,controlled clinical trial of transfusion requirements in critical care.Transfusion Requirements in Critical Care Investigators,Canadian Critical Care Trials Group.N Engl J Med,1999,340:409-417.
  • 3Besarab A,Bolton WK,Browne JK,et al.The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.N Engl J Med,1998,339:584-590.
  • 4Linde T,Wikstrom B,Andersson LG,et al.Renal anaemia treatment with recombinant human erythropoietin increases cardiac output in patients with ischaemic heart disease.Scand J Urol Nephrol,1996,30:115-120.
  • 5Zweier JL,Flaherty JT,Weisfeldt ML.Direct measurement of free radical generation following reperfusion of ischemic myocardium.Proc Natl Acad Sci USA,1987,84:1404-1407.
  • 6Werz O,Szellas D,Steinhilber D.Reactive oxygen species released from granulocytes stimulate 5-lipoxygenase activity in a B-lymphocytic cell line.Eur J Biochem,2000,267:1263-1269.
  • 7Chen HW,Chien CT,Yu SL,et al.Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes:mechanisms via ROS generation,iNOS and Hsp70.Br J Pharmacol,2002,137:771-781.
  • 8Kajstura J,Cheng W,Reiss K,et al.Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.Lab Invest,1996,74:86-107.
  • 9Palojoki E,Saraste A,Eriksson A,et al.Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats.Am J Physiol Heart Circ Physiol,2001,280:2726-2731.
  • 10Olivetti G,Quaini F,Sala R,et al.Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart.J Mol Cell Cardiol,1996,28:2005-2016.

共引文献7

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部